Attention-deficit/hyperactivity disorder, stimulants, statistics, and methodology [2]

Journal of Child and Adolescent Psychopharmacology

Volumn 16, Issue 4, 2006, Pages 507-508

  Poulton, A ^a  

^a NONE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE;

ATTENTION DEFICIT DISORDER; BEHAVIOR DISORDER; BODY HEIGHT; DISEASE ASSOCIATION; DOSE TIME EFFECT RELATION; DRUG DOSE REDUCTION; FOLLOW UP; HUMAN; LETTER; STATISTICAL ANALYSIS;

AMPHETAMINES; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BODY HEIGHT; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; DELAYED-ACTION PREPARATIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; FOLLOW-UP STUDIES; HUMANS; MULTICENTER STUDIES; STATISTICS; TREATMENT OUTCOME;

EID: 33750603304     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2006.16.507     Document Type: Letter

References (2)

1. Biederman J, Lopez FA, Boellner SW, Chandler MC: A randomized, double-blind, placebo-controlled, parallel-group study of SLI381 (Adderall XR) in children with attention-deficit/hyperactivity disorder. Pediatrics 110:258-266, 2002.
2. Faraone SV, Biederman J, Monuteaux M, Spencer T: Long-term effects of extended-release mixed amphetamine salts treatment of attention-deficit/ hyperactivity disorder on growth. J Child Adolesc Psychopharmacol 15:191-202, 2005.